Johnson & Johnson Today Announces That The U.S. FDA Has Granted Nipocalimab Breakthrough Therapy Designation For The Treatment Of Adults Living With Moderate-To-Severe Sjögren's Disease, A Debilitating And Chronic Autoantibody Disease With High...
Market Opens to Fresh Highs | Live Stock
Earnings Week Ahead: DIS, BABA, JD, CSCO, HD, OXY, SU, SHOP, AMAT, SPOT, and More
14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Investors Elect to Accelerate Market on Election Week | Weekly Buzz
Friday Market Finished with Records | Wall Street Today
Neomonoman : hope you are correct. fingers crossed